Cannabis exposure leads to genetic damage and accelerated aging, raising concerns about its transgenerational health effects and public health implications.
FDA pushes cancer drug developers to include overall survival data more frequently
For years, the FDA has allowed progression-free survival to serve as both a primary and surrogate endpoint to support speedy new cancer drug approvals. But
November 1, 2023